Good morning fellow blasters
After our euphoric news yesterday the questions across the dinner table last night were:
1. When will Mesoblast begin rolling out Remestemcel-L?
2. Where will they look to distribute this first? Will these be the hospitals that assisted with the trial or are there more potent avenues? Will there be a demographic style discussion of where the greatest good can be done?
3. how will they distribute the drug? Do they have a distribution network to enable fast roll out? Do they have sufficent stock to facilitate a broad sweep or will they target the hospitals that provide the best chance of gaining a foothold against ARDS?
Understanding that there are lives at stake and we have a chance to make an impact against ARDS, these questions have both humaitarian / philanthropic and financial leaning.
thoughts?
When, where and how?
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |